(Q31166026)

English

Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Andrew Yeates

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Latif Akintade

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Megan Del Valle

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Richard Y Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Elias M Schwam

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Carlos A Perdomo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

707-714

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18665662%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Prevalence and impact of medical comorbidity in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825080-00007

21 January 2018

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memantine for dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent developments in the pharmacological treatment of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global prevalence of dementia: a Delphi consensus study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of treatment response to rivastigmine in Alzheimer's dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil therapy in clinical practice: a randomized crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil for dementia due to Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurophysiological predictors of long term response to AChE inhibitors in AD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caregivers' preferences for the treatment of patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of cholinesterase inhibitors in dementia care needs rethinking

1 reference

https://pubmed.ncbi.nlm.nih.gov/18665662

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31166026&oldid=2195115404"